About Wallaby Medical
Wallaby Medical is a company based in Laguna Hills (United States) founded in 2016 by Bing Liu and Michael Alper. The company has 24 employees as of December 31, 2024. Wallaby Medical has completed 1 acquisition, including Phenox. Wallaby Medical operates in a competitive market with competitors including Conformal Medical, MicroTransponder, MIVI Neuroscience, Perfuze and BrainQ, among others.
- Headquarter Laguna Hills, United States
- Employees 24 as on 31 Dec, 2024
- Founders Bing Liu, Michael Alper
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Wallaby Medical Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Maison Capital
& 2 more
-
Employee Count
24
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Wallaby Medical
Unlock access to complete
Unlock access to complete
Funding Insights of Wallaby Medical
Investors in Wallaby Medical
Wallaby Medical has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Maison Capital, Qianhai Ark Asset Management and Changan Private Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Offline focused early & growth stage VC firm investing in China
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Multiple sectors are invested in by Changan Private Capital.
|
Locked | Locked | Locked |
Investor details for Wallaby Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Wallaby Medical
Wallaby Medical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Phenox.
Investment portfolio details for Wallaby Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of medical devices for interventional neurology
|
Locked | Locked | 2005 | Locked |
Complete acquisition details for Wallaby Medical
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Wallaby Medical
Detailed financials for Wallaby Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Wallaby Medical Comparisons
Peer comparison for Wallaby Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Wallaby Medical
Wallaby Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Conformal Medical, MicroTransponder, MIVI Neuroscience, Perfuze and BrainQ, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Stroke prevention device for atrial fibrillation patients is developed.
|
|
| Locked | Locked | Locked |
Neurostimulation for chronic pain management, tinnitus treatment and post-stroke rehabilitation
|
|
| Locked | Locked | Locked |
Catheters and devices for acute ischemic stroke treatment are developed.
|
|
| Locked | Locked | Locked |
A medical device for acute ischemic stroke treatment is developed.
|
|
| Locked | Locked | Locked |
AI-powered electromagnetic stimulation technology for stroke recovery is developed.
|
Detailed competitors of Wallaby Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Wallaby Medical
Complete news archive for Wallaby Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wallaby Medical
Wallaby Medical was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Wallaby Medical is headquartered in Laguna Hills, United States. It is registered at Laguna Hills, California, United States.
Michael Alper is the current CEO of Wallaby Medical. They have also founded this company.
As of Dec 31, 2024, the latest employee count at Wallaby Medical is 24.
Wallaby Medical was founded in 2016 in Laguna Hills, United States, within the medical devices sector. Focus is placed on developing the Avenir Coil System, an embolic coil system for endovascular embolization of intracranial aneurysms. Components include anatomically adaptive pushers, multi-filar technology, and super-elastic nitinol lasso detachment zones to aid intracranial navigation. Approvals such as CE Mark and FDA 510(k) have been obtained for the device.
Wallaby Medical's top competitors include MicroTransponder, Perfuze and Conformal Medical.
Wallaby Medical has made 1 acquisition, including Phenox.
Wallaby Medical has 3 investors. Key investors include Maison Capital, Qianhai Ark Asset Management, and Changan Private Capital.